4.7 Review

The Role of the Apelin/APJ System in the Regulation of Liver Disease

Journal

FRONTIERS IN PHARMACOLOGY
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2017.00221

Keywords

Apelin; APJ; liver disease; peptide; angiotensin II receptor like-1

Funding

  1. National Natural Science Foundation of China [81472232, 81270522, 81370537, 81672433, U1404310]
  2. Program for Science & Technology Innovation Talents in Universities of Henan Province (HASTIT) [13HASTIT024]
  3. Plan for Scientific Innovation Talent of Henan Province
  4. Fundamental Research Funds for the Central Universities [YS1407, 2050205]

Ask authors/readers for more resources

Apelin is an endogenous peptide that is a ligand for the APJ receptor (angiotensin II receptor like-1, AT-1). The apelin/APJ system is distributed in diverse periphery organ tissues. It has been shown that the apelin/APJ system plays various roles in physiology and pathophysiology of many organs. It regulates cardiovascular development or cardiac disease, glycometabolism and fat metabolism as well as metabolic disease. The apelin/APJ system participates in various cell activities such as proliferation, migration, apoptosis or inflammation. However, apelin/APJ function in the liver is still under investigation. In the liver, the apelin-APJ system could play an inhibitory role in liver regeneration and promote Fas-induced apoptosis. It may participate in the formation of hepatic fibrosis or cirrhosis, and even cancer. In this review, we summarize the role of the apelin/APJ system in liver disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available